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ABSTRACT: Fluorine being not substantially present in the
chemistry of living beings is an attractive element in tailoring
novel chemical, biophysical, and pharmacokinetic properties of
peptides and proteins. The hallmark of ribosome-mediated
artificial amino acid incorporation into peptides and proteins is
a broad substrate tolerance, which is assumed to rely on the
absence of evolutionary pressure for efficient editing of artificial
amino acids. We used the well-characterized editing proficient
isoleucyl-tRNA synthetase (IleRS) from Escherichia coli to
investigate the crosstalk of aminoacylation and editing activities
against fluorinated amino acids. We show that translation of
trifluoroethylglycine (TfeGly) into proteins is prevented by
hydrolysis of TfeGly-tRNAIle in the IleRS post-transfer editing
domain. The remarkable observation is that dissociation of
TfeGly-tRNAIle from IleRS is significantly slowed down. This finding is in sharp contrast to natural editing reactions by tRNA
synthetases wherein fast editing rates for the noncognate substrates are essential to outcompete fast aa-tRNA dissociation rates.
Using a post-transfer editing deficient mutant of IleRS (IleRSAla10), we were able to achieve ribosomal incorporation of TfeGly
in vivo. Our work expands the knowledge of ribosome-mediated artificial amino acid translation with detailed analysis of natural
editing function against an artificial amino acid providing an impulse for further systematic investigations and engineering of the
translation and editing of unusual amino acids.
Numerous reports describing the influence of artificialamino acid side chains containing one, few, or several
fluorine atoms on various peptide/protein properties have
provided insights into the unpredictable ways in which this
unique element engages in intermolecular interactions within
protein environments.1 We recently reported that P1 position
mutants of the protease inhibitor BPTI containing either (2S)-
4,4-difluoroethylglycine (DfeGly) or (2S)-4,4,4-trifluoroethyl-
glycine (TfeGly) exhibit wild-type level inhibitor activity against
β-trypsin, whereas the hydrocarbon parent BPTI containing
(2S)-ethylglycine ((2S)-2-aminobutanoic acid (Abu)) is
markedly less effective at inhibiting this enzyme.2 In the
protein environment of an enzyme active site, crystal structures
supported a role for the fluorinated side chains in which
multipolar interactions with protein amide fragments and a
potential weak hydrogen bond to a structural water dominate.
This is of course a very different kind of behavior than that
observed, for example, by Marsh and co-workers in the
environment of the hydrophobic core of a helical bundle; here,
enhanced thermostability mediated by fluorine was based on
increased buried hydrophobic surface area and volume.3 In
another recent study using DfeGly and TfeGly, we showed that
side chain fluorination has differential effects on the protease
stability of a model peptide substrate depending upon the
number of fluorine atoms, the position of the unnatural amino
acid, and the particular enzyme studied.4
The studies described above were made possible by chemical
synthesis of the fluorinated building blocks DfeGly and TfeGly,
followed by automated solid-phase peptide synthesis (SPPS).
However, this method has limitations with respect to the length
of the polypeptide that can be synthesized. Thus, ribosomal
synthesis would be a valuable tool for the synthesis of large
proteins containing such artificial residues.
Ribosomal polypeptide synthesis is mediated by aminoacyl-
tRNA synthetases (AARSs). These central enzymes in protein
synthesis have been shown to be often unable to discriminate
between sterically and biophysically similar canonical (cAAs,
Figure 1b, left) and noncanonical (ncAAs, Figure 1b, right)
amino acids.5 Thus, DfeGly and TfeGly have the potential to be
accepted by the natural translation apparatus due to their
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similar calculated van der Waals volume and hydrophobicity
compared to the natural substrates Ile, Leu, Val, and Met.6
AARSs display a conserved mechanism of catalysis (Figure 1a,
Aminoacylation).7 First, they use the energy stored in ATP to
activate the amino acid (AA), forming an aminoacyl-adenylate
intermediate (AARS−AA-AMP) (Figure 1a, AA activation). In
the second step, the AA is transferred to its corresponding
tRNA (Figure 1a, AA transfer to tRNA). At the end of this
process the charged tRNA dissociates to solution (Figure 1a,
AA-tRNA dissociation from AARS) and can take part in
translation at the ribosome. Fidelity of ribosomal peptide
synthesis highly depends on the ability of AARSs to
discriminate efficiently against noncognate AAs (Figure 1b).
Some AARS families are unable to distinguish cognate (Figure
1b, left) from noncognate AAs in the aminoacylation reaction
(Figure 1a, aminoacylation) alone. These enzymes possess
additional editing activities in order to hydrolyze erroneously
activated amino acids and misacylated tRNAs (Figure 1a,
hydrolytic editing).8
In order to enhance translation of noncanonical amino acids
several approaches were taken. One is to alter the substrate
specificity by reengineering of the AARSs binding pockets.
Successful examples comprise incorporations of 3-iodopheny-
lalanine, 3-chlorophenylalanine and 3-bromophenylalanie and
3-iodotyrosine by engineered PheRS and TyRS, respec-
tively.9−12 Oki et al. further increased the substrate specificity
of the engineered TyrRS toward 3-iodotyrosine by trans-
plantation of the PheRS editing domain, which prevents
translation of Tyr.13 Finally, the use of screening systems in
combination with rational or computational design of binding
and editing domain libraries of the AARSs has highly increased
the number and selectivity of ncAA translations.14
No evolutionary pressure existed for the discrimination of
AARSs against artificial AAs (Figure 1b, right (i)), to which
DfeGly and TfeGly belong, because they were not encountered
by the enzymes during evolution. Because of the lack of
comprehensive studies, little is known about the possible
proofreading activity of AARSs against such building blocks.
In all class I AARSs, the Rossmann fold that comprises the
catalytic domain is split by an inserted α/β domain (connective
peptide 1, CP1). CP1 is greatly enlarged in IleRS, ValRS, and
LeuRS, generating a distinct catalytic site for the hydrolysis of
misacylated tRNAs (Figure 1a, post-transfer editing).8,15 It has
been proposed that this dedicated editing site acts as a second
sieve that rejects noncognate AAs on the basis of steric issues
and/or different hydrophobicity.16−20 Although the emerging
evidence indicates that the mechanism is more compli-
cated,21,22 post-transfer editing undoubtedly acts as a powerful
second check that prevents stable aminoacylation of tRNAs
with noncognate AAs. In ILVRSs (IleRS, LeuRS, ValRS) the
synthetic and editing sites are approximately 30−40 Å away
from each other.8 The AA covalently bound to tRNA is
transferred for proofreading from the synthetic to the editing
site by translocation of the 3′-end of AA-tRNA.8 Besides post-
transfer editing, AARSs may also employ pretransfer editing
(Figure 1a) within the synthetic site.8 In tRNA-independent
pretransfer editing, noncognate aminoacyl-adenylate intermedi-
ates are hydrolyzed independently of the presence of tRNA.23
In some cases, like in IleRS, tRNA may induce a conformational
change that organizes the synthetic site for enhanced editing
(tRNA-dependent pretransfer editing (Figure 1a)).8,24 The
contribution of each pathway to overall editing differs among
various enzymes; for ILVRSs post-transfer editing represents
the major pathway.8
Disabling of ILVRS post-transfer editing has been shown to
allow the translation of several ncAAs that are efficiently
discriminated against by the wild-type enzymes. Different
working groups have used rational site-directed mutagenesis of
the editing domain or random mutagenesis in combination
with a selection system to identify LeuRS and ValRS variants,
respectively, that enabled the incorporation of numerous
aliphatic ncAAs.25−28 Furthermore, Pezo et al. demonstrated
that disruption of the editing site in IleRS by substituting 10
residues in the post-transfer editing domain with alanine leads
to a mutant (IleRSAla10) that facilitates the ribosomal
translation of norvaline, O-methylserine, norleucine, S-methyl-
cysteine, and O-methylthreonine.29
Interestingly, in none of these reports was the observation
made that the crosstalk between synthetic and editing pathways
of ncAAs differs from that of the 20 cAAs, and this may be true
for side chains containing only elements from the cAA pool
that were encountered by the AARSs during evolution.
However, fluorine is absent from this pool and has unique
stereoelectronic properties that arise from a combination of
small size, very low polarizability, and the strongest inductive
effect found among all the chemical elements30 and
consequentially might affect interactions and chemical steps
mediated by AARSs in ways that have not yet been observed.
Therefore, we sought to probe the compatibility of several
aliphatic fluorinated amino acids with the natural ribosomal
translation machinery by investigating the aminoacylation and
editing activities of the AARSs against them, as well as their
translation into polypeptides.
■ RESULTS AND DISCUSSION
Synthetic Active Site of ValRS and in Particular IleRS
Shows Relaxed Substrate Tolerance toward the
Selected Fluorinated AAs. Investigating the first step of
aminoacylation (Figure 1a, AA activation) delivers important
Figure 1. (a) Overall kinetic scheme for hydrolytic editing by AARSs.
Additionally, nonenzymatic editing is possible by release of the
reaction intermediates and their hydrolysis free in solution. (b)
Nomenclature used in this work for referring to amino acids.
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information about the likelihood of ribosomal translation of
noncognate AAs. Activation of a specific substrate by an AARS
is based on optimal binding at the ground and transition state,
which can be investigated by Michaelis−Menten kinetic
experiments. Both states are strongly influenced by the steric
size and physicochemical properties of the AA substrate.18,31
The parameter ( )kK rel
cat
M
, which is the ( )kKcatM of the noncognate
substrate divided by( )kKcatM of the cognate substrate is often used
to show how efficiently the noncognate substrate is utilized




substrate that is as good as the cognate one. In the absence of
editing, a strong correlation between AA activation and
ribosomal translation can be assumed.
However, this correlation might, besides editing, be further
complicated by other steps of aminoacylation (Figure 1a), or
arise from weaker or stronger binding to elongation factor (EF-
Tu in prokaryotes like Escherichia coli (E. coli)) or perturbed
interactions at the ribosome.
The determined ( )kK rel
cat
M
values for the activation of various
fluorinated AAs (Figure 2a) by the different class Ia AARSs
from E. coli (IleRS, ValRS, MetRS, LeuRS) are shown in Figure




better the activation of the fluorinated AAs by a certain AARS
compared to its cognate cAA. Additionally, this is represented
by a color code: green, cyan, and yellow indicate a relatively
good substrate, whereas black and red indicate only marginal or
no observed activation. Table S1 shows the detailed kinetic
values. On the basis of these results, among the class Ia AARSs,
only ValRS and IleRS efficiently activate some selected
fluorinated amino acids that have a different carbon backbone
and structure than their cognate substrates (IleRS: MfeGly,
DfeGly, TfeGly, (2S,3R)-TfVal; ValRS: MfeGly, TfeGly). We
have investigated the crystal structures of the AARSs that exist
in the PDB (Supporting Information, Figure S1). From our
analysis we conclude that this relaxed substrate tolerance of
ValRS and IleRS is connected to the arrangement of the surface
of the hydrophobic binding pockets of the enzymes, which, in
the cases of MetRS and LeuRS reflect the shape of their
cognate substrates, but in the cases of IleRS and ValRS the
pockets display not high shape complementarity but rather a
general hydrophobic cavity (Supporting Information, Section
1.2, Figure S1). In the case of MetRS a particularly important
determinant for its highly discriminating synthetic active site is
the induced-fit mechanism of its binding pocket, as described
by Serre et al.,32 which differs from the preformed binding
pockets of IleRS, ValRS, and LeuRS.
Altogether, the activation rates of the fluorinated AAs by
IleRS, LeuRS, and ValRS range from several hundred- to several
thousand-fold lower than the values of the respective natural
substrates (Figure 2, Table S1). These values clearly show that
the fluorinated AAs are markedly less suitable substrates for the
AARSs than their natural substrates. These activation data are
in good agreement with previous reports33−38 of detailed
kinetic studies for the activation of (2S,3R)-TfVal by ValRS and
IleRS, and TfLeu and HfLeu by LeuRS as well as their effective
ribosomal translation. The values are in a similar range
compared to new amino acid activations (MfeGly, DfeGly,
TfeGly) that we discovered in this study (Figure 2, Table S1).
This suggests that they could be efficiently translated using the
natural translation machinery in the absence of the cognate
Figure 2. (a) Chemical structure of natural substrates of class Ia AARSs and putative fluorinated analogues. 1: (2S)-4,4,4-trifluoroethylglycine
(TfeGly), 2: (2S)-4,4-difluoroethylglycine (DfeGly), 3: (2S)-4-monofluoroethylglycine (MfeGly), 4: (2S)-4,4-difluoropropylglycine (DfpGly), 5:
(2S,4S,4R)-5,5,5-trifluoroleucine (TfLeu), 6: (2S)-5,5,5,5′,5′,5′-hexafluoroleucine (HfLeu), 7: (2S,2R)-3,3,3-trifluoroalanine (TfAla), 8: (2S,3R)-
4,4,4-trifluorovaline ((2S,3R)-TfVal), 9: (2S,3S)-4,4,4-trifluorovaline ((2S,3S)-TfVal), 10: (2S,2R)-4,4,4,4′,4′,4′-hexafluorovaline (HfVal), 11:
(2S,2R)-6,6,6-trifluoronorleucine (TfNLeu), (b) Kinetic data that were determined in this study for the activation of these fluorinated AAs by the
indicated class Ia AARSs.
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AARS substrate, i.e., in an appropriate auxotrophic genetic
background; if such an attempt proved inefficient, supplemen-
tation of a vector that encodes the appropriate AARS gene, and
would thus increase the amount of this biocatalyst in the cell,
could improve the outcome.34
Discovery and Investigation of Editing Function of
IleRS against TfeGly. We chose TfeGly as a model artificial
AA in order to probe ribosomal incorporation via IleRS.
However, despite detected activation with IleRS (Figure 2,
Table S1) no incorporation of TfeGly is observed in an Ile
auxotrophic strain with TfeGly supplementation in the
presence of increased cytosolic concentrations of IleRS (see
Supporting Information, Figure S3). A possible reason for this
observation is that TfeGly is edited by IleRS (Figure 1a,
hydrolytic editing).
To address this issue, we investigated in vitro the
proofreading and two-step aminoacylation of TfeGly by E.
coli IleRS. A substantial increase in TfeGly-dependent AMP
accumulation clearly demonstrates that this artificial AA is
edited by the wild-type enzyme (Figure 3a,b). The overall
editing of TfeGly by IleRS is 100-fold reduced relative to the
cAA valine (0.015 s−1 vs 1.56 s−1 for Val).39 Nevertheless, this
activity prevents stable formation of TfeGly-tRNAIle, as
confirmed in an independent assay that used [32P]-labeled
tRNA (Figure 3d). Our data (Figure 3; Supporting
Information, Section 1.7) further indicate that editing against
TfeGly, the fluorinated synthetic Abu derivative, is significantly
lower than editing of Abu, which is a natural ncAA40,41 that is
edited with an efficiency similar to canonical noncognate
substrates.27,42−46
Kinetic analysis demonstrates that IleRS edits TfeGly via a
tRNA-independent route (Figure 3a) in a manner similar to
valine.39 Post-transfer editing can be measured independently
of overall editing as enzyme deacylation activity against the
preformed misacylated tRNA. Using this assay under single-
turnover conditions (excess enzyme), we were able to show
that IleRS also deacylates TfeGly-tRNAIle (Figure 3c), yet with
a rate that is 1300-fold slower than that reported24 for Val-
tRNAIle (0.048 s−1 for TfeGly-tRNAIle and 64 s−1 for Val-
tRNAIle).
To measure the contribution of post-transfer editing to
TfeGly proofreading, IleRSAla10 (Supporting Information,
Section 1.5), previously reported29 as a post-transfer editing
inactive mutant, was produced and kinetically characterized
(Supporting Information, Section 1.7). We confirmed a
complete loss of TfeGly-tRNAIle deacylation activity in this
variant (Figure 3c), justifying its further use in this analysis. As
expected tRNA-independent editing, located in the synthetic
site, is not significantly disturbed (Figure 3a). Importantly,
IleRSAla10 charges tRNAIle with TfeGly (Figure 3d),
confirming that post-transfer editing prevents TfeGly-tRNAIle
accumulation by the wild-type enzyme. Independently
measured transfer of TfeGly to tRNAIle yields a value of 0.5
s−1 or higher, which is about 10-fold lower than that of the
cognate AA Ile (Supporting Information, Figure S8). Kinetic
analysis thus provides evidence that TfeGly is not well
discriminated at the level of kcat (Supporting Information,
Table S1) and ktrans in the IleRS synthetic pathway.
It has been shown that the highly conserved aspartate (Asp
342 in E. coli IleRS) forms a salt bridge with the α-NH3
+ group
of the AA attached to tRNA, acting as the main determinant of
the IleRS post-transfer editing site.47 Its substitution with
alanine abolishes hydrolysis of Val-tRNAIle.24,48 To address the
determinants of TfeGly editing, we measured deacylation of
TfeGly-tRNAIle by IleRS D342A under single-turnover
conditions. Interestingly, the mutant exhibits the same activity
as the wild-type enzyme, showing that D342 does not
significantly participate in the post-transfer editing of TfeGly
(Supporting Information, Table S2). Steric constraints imposed
by the structurally distinct side chain may promote distinct
positioning of TfeGly-tRNAIle in the editing site. This may be
further facilitated by abrogation of the “anchoring” salt bridge
due to the electron withdrawing effect of the CF3 group, which
decreases the pKa value of the α-NH3
+ group of TfeGly.49 Our
finding thus supports the notion that AARS proofreading of
artificial AAs may rely on different active site determinants
compared to cAAs.
Wild-type IleRS does not accumulate TfeGly-tRNAIle (Figure
3d), despite the fast synthetic steps and slow deacylation of
TfeGly-tRNAIle. This was intriguing because the measured rate
of deacylation was actually at the level of post-transfer editing
of the cognate Ile-tRNAIle (0.058 s−1),24 which evades editing
and readily accumulates in solution. We have previously50
shown that the fate of aminoacylated tRNA is determined by its
kinetic partitioning between dissociation from the enzyme and
deacylation at the editing domain (Figure 4). In the case of
TfeGly-tRNAIle, slow deacylation is still kinetically favored,
presumably due to reduced efficiency of the dissociation step.
In contrast to TfeGly, the cognate product readily
accumulates in solution, because kinetic partitioning of Ile-
tRNAIle is poised to favor product dissociation. The presumed
slow dissociation of TfeGly-tRNAIle from the enzyme is further
supported with the observed slow TfeGly-tRNAIle accumulation
by IleRSAla10. This variant activates TfeGly (0.3 s−1) and
transfers it to tRNAIle (0.5 s−1) with rates that are significantly
faster than the steady-state rate of its misaminoacylation (0.002
s−1; Figure 3d). This suggests that product (TfeGly-tRNA)
dissociation is the rate-limiting step, and its rate may be
approximated by the misaminoacylation rate.
To further address this issue, we introduced another
substitution, T243R, in the background of D342A IleRS. The
Figure 3. Editing and aminoacylation of TfeGly by wild-type IleRS
(wt) and IleRSAla10 (10Ala): (a) AMP formation by 2 μM enzyme in
the presence of 20 mM DL-TfeGly and in the absence of tRNAIle; (b)
AMP formation by 2 μM enzyme in the presence of 20 mM DL-TfeGly
and 10 μM tRNAIle; (c) single-turnover deacylation of preformed
TfeGly-tRNAIle using 10 μM enzyme or no enzyme (nonenzymatic);
(d) aminoacylation of tRNAIle with DL-TfeGly in the presence of 1 μM
enzyme.
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rationale was to reverse a kinetic partitioning of TfeGly-tRNAIle
by a mutation that may promote the dissociation step. We
assumed that slow post-transfer editing of TfeGly-tRNA would
not be able to prevent its accumulation in this case, as it could
be outcompeted by more rapid TfeGly-tRNAIle dissociation
step. We have previously shown that the T243R substitution
lowers affinity of the enzyme for Val-tRNAIle.39 Therefore, we
produced the T243R/D342A variant and showed that it
significantly accumulates TfeGly-tRNAIle (Figure 5a,b) as
anticipated. Separately tested post-transfer editing of this
mutant showed a deacylation rate of TfeGly-tRNA (kdeacy =
0.047 s−1; Supporting Information, Table S2) equal to that of
the wild-type enzyme, which does not accumulate TfeGly-
tRNAIle. This confirms that TfeGly-tRNAIle evades active
T243R/D342A editing, because of its enhanced dissociation.
The misacylated tRNAs that have escaped editing in cis
(operating via translocation of the 3′-end of the AA-tRNA from
the synthetic to the editing site) may however rebind the
enzyme from solution for editing in trans.52 To analyze
distribution of TfeGly-tRNAIle between the enzyme-free and
enzyme-bound forms, activated EF-Tu was added to the
misaminoacylation mixture of T243R/D342A. EF-Tu−TfeGly-
tRNAIle complex formation shifted the equilibrium toward the
enzyme-free form and promoted misacylation (Figure 5a,b). In
another experiment, we followed misaminoacylation using a
higher concentration of T243R/D342A (5 μM) to promote
association of TfeGly-tRNAIle with the enzyme and editing
(Figure 5d). No misaminoacylated tRNA was detected under
these conditions (Figure 5d). This confirms that T243R/
D342A opposite behavior relative to the wild-type enzyme is a
consequence of reversed kinetic partitioning that favors TfeGly-
tRNAIle dissociation. Similarly, EF-Tu does not show any
significant effect on the rate or plateau of TfeGly-tRNA
formation by wild-type IleRS or any of the single mutants
(Figure 5c). T243R IleRS performs all reactions with TfeGly
equally to the wild-type enzyme (Supporting Information,
Table S2).
The presented data support a model wherein kinetic
partitioning of aminoacylated tRNA (Figure 4) dictates the
contribution of synthetic and editing pathways. In general,
rapid editing of noncognate AAs outcompetes dissociation of
the respective misacylated tRNAs, while the opposite is true for
the cognate systems; i.e., editing here is significantly slower
than AA-tRNA dissociation. Perturbation of the partitioning of
aminoacylated tRNAs, introduced by a protein mutation
(Cvetesic et al.50), or by a novel chemical feature of the
artificial AA substrate (this work), may significantly influence
misaminoacylation activity of the enzyme. Here we show that
the unique stereoelectronic properties of fluorine govern
distinct TfeGly-tRNAIle partitioning within the editing site,
permitting the weak AA-tRNA deacylation activity to function-
ally contribute to protein quality control.
In Vivo Translation of TfeGly with Post-Transfer
Inactive IleRS. In the previous section we discussed that
wild-type IleRS hydrolyzes TfeGly-tRNAIle, which prevents
TfeGly from being translated in the place of Ile in vivo. Our
experiments show that the mutant IleRSAla10 is totally
defective in post-transfer editing and thus accumulates
TfeGly-tRNAIle in vitro. Therefore, we further tested both the
wild-type and this mutant for their in vivo translation of TfeGly
into our model peptide VW18Ile53 (Supporting Information,
Section 1.3) that was expressed in the absence of Ile and in the
presence of 1 mM TfeGly.
Using this approach, we detected ribosomal translation of
TfeGly in place of Ile only in the presence of the post-transfer
inactive IleRS mutant (Figure 6). To the best of our knowledge,
this is the first report of successful ribosomal translation of
TfeGly. We also tested several other fluorinated amino acids.
We detected an increase in the rate of aminoacylation and in
vivo misincorporation of TfNVal using IleRSAla10 relative to
the wild-type enzyme (Supporting Information, Figures S6 and
S7). This indicates that TfNVal influences the partitioning of
AA-tRNA in a manner similar to TfeGly, making inactivation of
post-transfer editing important for its efficient misacylation. We
did not observe this effect with TfIle and TfVal (Supporting
Information, Figures S6 and S7) that have been commonly
employed for ribosomal translation relying on IleRS.
Figure 4. Kinetic partitioning of IleRS post-transfer proofreading. The
values for both processes (dissociation and hydrolysis) obtained for
TfeGly-tRNAIle in this study are compared with values of our previous
studies with IleRS and Ile-tRNAIle and Val-tRNAIle.24,51
Figure 5. (a and b) Misaminoacylation of tRNAIle with TfeGly by 1
μM T243R/D342A IleRS in the presence or absence of activated EF-
Tu on different time scales. (c) Misaminoacylation of tRNAIle with
TfeGly by 2 μM wild-type IleRS in the presence or absence of
activated EF-Tu. (d) Misaminoacylation and AMP formation by 5 μM
T243R/D342A IleRS in the presence of TfeGly.
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■ CONCLUSIONS
It can be assumed that no evolutionary pressure existed for the
discrimination of AARSs against artificial AAs, because they
were not encountered by these enzymes during evolution,
suggesting that these AAs may escape translational quality
control mechanisms. The lack of comprehensive studies
prompted us to investigate the details of AARS misaminoacy-
lation and editing mechanisms against artificial AAs, using
TfeGly and IleRS as a model system. Fluorinated AAs such as
TfeGly can increase the pharmacokinetics of peptide
pharmaceuticals and display potential in the engineering of
enzyme-based catalysts that are resistant to organic solvents, so-
called “Teflon-proteins”.54−56 Surprisingly, we observed
efficient proofreading of TfeGly by IleRS, which hinders its
incorporation into polypeptides. However, we demonstrated
that post-transfer editing of IleRS against TfeGly-tRNAIle is also
strongly defective. At the same time, rapid transfer of TfeGly to
tRNA prevents significant pretransfer editing contributions to
overall proofreading. Our finding that IleRS deacylation activity
against TfeGly-tRNAIle is reduced to the level displayed by
IleRS against its cognate product Ile-tRNAIle, and at the same
time prevents its misaminoacylation, was puzzling. This finding
supports the assumption that the proofreading mechanism of
natural AARSs is generally not very effective for artificial AAs,
as a consequence of the lack of evolutionary pressure to edit
these out.57 Using various kinetic approaches we have provided
clear evidence that the effectiveness of TfeGly-tRNAIle synthesis
and subsequent TfeGly incorporation into peptides in vivo are
not determined solely by the deacylation step (Figure 3c),
which is typically rapid in the case of editing substrates, but
slow in the case of TfeGly. Instead, the essential factor is the
ratio between the rates of TfeGly-tRNAIle dissociation and
hydrolysis that determine the kinetic partitioning of the
aminoacylated tRNA within the IleRS editing domain (Figure
4). In this context, both features differ remarkably for TfeGly in
comparison to those known thus far for the proofreading of
editing substrates such as valine. We hypothesize that the
dramatically reduced dissociation rate of TfeGly-tRNAIle results
from specific interactions between TfeGly and residues of the
isoleucine-AARS binding pocket induced by the fluorine
substituents. This effect has not been reported for tRNAs
with AAs containing only elements from the cAA pool. Finally,
using the IleRS variant with abolished post-transfer editing we
have observed, for the first time, the ribosomal translation of
TfeGly. This work expands our understanding of unnatural
protein translation with the discovery and investigation of a
natural editing function against artificial amino acids and
demonstrates that in such cases the routinely used approach of
AARS overexpression for the incorporation of artificial AAs is
not always sufficient. This work provides an impulse for further
systematic investigations and engineering of the translation and
editing of unusual amino acids.
■ ASSOCIATED CONTENT
*S Supporting Information
The Supporting Information is available free of charge on the
ACS Publications website at DOI: 10.1021/acscentsci.6b00339.
Detailed materials and methods, nucleotide sequences,
amino acid sequences, vector and strain information,
analysis of AARS binding pockets, details about the
model peptide VW18Ile, incorporation attempts of
TfeGly in the presence of increased cytosolic concen-
trations of IleRS or ValRS, respectively, representation of
the location of the mutations in the post-transfer editing
mutant IleRSAla10, in vitro aminoacylation and in vivo
translation of TfNVal, TfIle, TfVal, aminoacylation and










§These authors (J.V and M.D.) contributed equally.
Notes
The authors declare no competing financial interest.
■ ACKNOWLEDGMENTS
J.V. is a member of the graduate school “Fluorine as key
element” (GRK 1582) of Deutsche Forschungsgemeinschaft
(DFG) and the Cluster of Excellence “UniCat” and thankful for
financial support. T.B. acknowledges funding by the EU
(SYNPEPTIDE). I.G.-S. acknowledges support from the
Croatian Science Foundation (Grant 09.01/293). Stella Vukelic
is acknowledged for providing TfNVal, Holger Erdbrink for
providing TfVal, and Patrick J. Loll and Anne Diehl for
providing the vector pETHSUL58(SI). The authors thank Dr.
Allison Ann Berger for proofreading of the manuscript.
■ ABBREVIATIONS
ILVRSs, IleRS, LeuRS, ValRS; cAA, canonical amino acid;
ncAA, noncanonical amino acid; AA, amino acid; LC-ESI-MS,
liquid chromatography electrospray ionization mass spectrom-
etry; CP1, connective polypeptide 1 (IleRS post-transfer editing
domain); AARS, aminoacyl-tRNA synthetase; AA-tRNA,
aminoacyl-tRNA; Abu, α-aminobutyric acid; ATP, adenosine-
5′-triphosphate; MfeGly, 4-monofluoroethylglycine; DfeGly,
4,4-difluoroethylglycine; TfeGly, 4,4,4-trifluoroethylglycine;
TfIle, 5,5,5-trifluoroisoleucine; TfNVal, 5,5,5-trifluoronorvaline;
TfVal, 4,4,4-trifluorovaline; E. coli, Escherichia coli; kcat, turnover
Figure 6. Effect of in vivo post-transfer editing of TfeGly. LC-ESI-MS
experiment of VW18Ile variants expressed in the absence of Ile with
supplementation of 1 mM TfeGly. For translation either the wild-type
IleRS (a) or the post-transfer editing deficient mutant IleRSAla10 (b)
was coexpressed. The monoisotopic masses of the 5-fold charged
variants of the model peptide VW18Ile, that has just one Ile position,
are displayed. Calculated monoisotopic masses for Ile substitution: Val
= 605.78, Leu/Ile = 608.57, TfeGly = 613.75, Met = 612.19.
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number; KM, Michaelis−Menten constant; kobs, observed rate
constant; rel, relative; tRNA, transfer RNA; mRNA, messenger
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